Systematic Review of the Treatment of Early Lyme Disease

Authors: Loewen P.S.; Marra C.A.; Marra F.

Source: Drugs, Volume 57, Number 2, February 1999 , pp. 157-173(17)

Publisher: Adis International

Abstract:

Lyme disease is a rapidly emerging infectious disease and there are still many unanswered questions with respect to appropriate laboratory tests required for diagnosis of early Lyme disease, types of antimicrobials required for treatment and duration of therapy.

A qualitative systematic review was used to summarise the existing data for the treatment of early Lyme disease. Eleven antibacterial therapy trials and 3 cost-effectiveness analyses met the inclusion criteria for this review. Antibacterial regimens that have been studied include phenoxymethylpenicillin (penicillin V), amoxicillin, amoxicillin/probenecid, tetracycline, doxycycline, cefuroxime axetil, erythromycin, roxithromycin, azithromycin and ceftriaxone.

The data support the use of oral -lactam antibacterials [phenoxymethylpenicillin (penicillin V), amoxicillin, cefuroxime axetil] and oral tetracyclines as effective first-line treatment modalities for early Lyme disease. Oral macrolides are considered second-line agents as their clinical efficacy has been less than that of the -lactams and tetracyclines. Courses of therapy ranging from 10 to 21 days are supported by the available evidence, although the optimal duration of therapy is unknown.

Keywords: Reviews-on-treatment; Lyme-disease, treatment; Phenoxymethylpenicillin, therapeutic-use; Amoxicillin, therapeutic-use; Erythromycin, therapeutic-use; Probenecid, therapeutic-use; Macrolides, therapeutic-use; Cefalosporins, therapeutic-use; Tetracyclines, therapeutic-use; Antibacterials, therapeutic-use; Ceftriaxone, therapeutic-use; Azithromycin, therapeutic-use; Roxithromycin, therapeutic-use; Cefuroxime-axetil, therapeutic-use; Doxycycline, therapeutic-use; Minocycline, therapeutic-use

Language: English

Document Type: Review article

Affiliations: 1: Faculty of Pharmaceutical Sciences, University of British Columbia, CSU-Pharmaceutical Sciences, Vancouver Hospital and Health Sciences Centre, Vancouver, British Columbia, Canada *

Publication date: 1999-02-01

• In this: publication
• By this: publisher
• In this Subject: Pharmacology ,  Therapeutics & Alternative Medicine
• By this author: Loewen P.S. ;  Marra C.A. ;  Marra F.

Website © Publishing Technology. Article copyright remains with the publisher, society or author(s) as specified within the article.

• Terms and conditions
• Privacy policy
• Information for advertisers